The store will not work correctly when cookies are disabled.
ID: ALA11081
Max Phase: Preclinical
Molecular Formula: C11H18N2O
Molecular Weight: 194.28
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)N(C)CC#CCN1CCCC1
Standard InChI: InChI=1S/C11H18N2O/c1-11(14)12(2)7-3-4-8-13-9-5-6-10-13/h5-10H2,1-2H3
Standard InChI Key: HWYHDWGGACRVEH-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 194.28 | Molecular Weight (Monoisotopic): 194.1419 | AlogP: 0.56 | #Rotatable Bonds: 2 |
Polar Surface Area: 23.55 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.18 | CX LogP: 0.32 | CX LogD: -0.53 |
Aromatic Rings: 0 | Heavy Atoms: 14 | QED Weighted: 0.60 | Np Likeness Score: -1.32 |
References
1. Bradbury BJ, Baumgold J, Paek R, Kammula U, Zimmet J, Jacobson KA.. (1991) Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides., 34 (3): [PMID:1848294] [10.1021/jm00107a029] |
2. Moon MW, Chidester CG, Heier RF, Morris JK, Collins RJ, Russell RR, Francis JW, Sage GP, Sethy VH.. (1991) Cholinergic activity of acetylenic imidazoles and related compounds., 34 (8): [PMID:1875333] [10.1021/jm00112a002] |
3. Nilsson BM, Ringdahl B, Hacksell U.. (1988) Derivatives of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide., 31 (3): [PMID:3346873] [10.1021/jm00398a015] |
4. Bradbury BJ, Baumgold J, Jacobson KA.. (1990) Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides., 33 (2): [PMID:2153827] [10.1021/jm00164a044] |
5. Sanders KB, Thomas AJ, Pavia MR, Davis RE, Coughenour LL, Myers SL, Fisher S, Moos WH. (1992) Cholinergic agents: aldehyde, ketone, and oxime analogues of the muscarinic agonist UH5, 2 (8): [10.1016/S0960-894X(00)80535-1] |